Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists

Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists

US Patent 8501786 · Granted Aug 6, 2013

Estimated economic value: $72,172,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Display panel and driving method therefor, and display device2025
Driving method for display panel, and display device2025
Display device2025
Compounds and compositions for treating conditions associated with NLRP activity2025
Oil-soluble conductive additive and preparation method therefor2025
Factor XIa inhibitors2025
1-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharm2025
Composition and methods for MRNA vaccines against novel omicron coronavirus infe2025
Compositions and methods of mRNA vaccines against novel coronavirus infection2025
CD25 antibodies2025
Anti-tumor compound and preparation method and use thereof2024
Polycyclic compound inhibiting MNK1 and MNK22024